Pharmacy World and Science

, Volume 19, Issue 2, pp 70–72 | Cite as

Are SSRIs true antidepressant drugs? a plea for the re-evaluation of their therapeutic potential and safety.

  • Anton J.M. Kasteleijn‐Nolst TrenitÄ


Public Health Internal Medicine Therapeutic Potential Antidepressant Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, Munoz R. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972;26:57‐63.Google Scholar
  2. 2.
    Spitzer RL, Endicott J, Robins E. Research diagnostic criteria. Rationale and reliability. Arch Gen Psychiatry 1978;35:773‐82.Google Scholar
  3. 3.
    APA Task Force on DSM‐IV. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Washington, DC; American Psychiatric Association, 1994.Google Scholar
  4. 4.
    Guy W. ECDEU assessment manual for psychopharmacology. Revised ed, 1976. Washington, DC: US Department of Health, Education and Welfare, 1976.Google Scholar
  5. 5.
    Danish University Antidepressant Group. Paroxetine: a selec tive serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicentrer study. J Affect Disord 1990;18:289‐99.Google Scholar
  6. 6.
    Danish University Antidepressant Group. Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology (Berl) 1986:90:131‐8.Google Scholar
  7. 7.
    Song F, Freemantle N, Sheldon TA, House A, Watson P, Long A, Mason J. Selective serotonin reuptake inhibitors: meta‐analysis of efficacy and acceptability. Brit Med J 1993:306:683‐7.Google Scholar
  8. 8.
    Montgomery SA, Henry J, McDonald G, Dinan T, Lader M, Hindmarch I, Clare A, Nutt D. Selective serotonin reuptake inhibitors: meta‐analysis of discontinuation rates. Int Clin Psychopharmacol 1994;9:47‐53.Google Scholar
  9. 9.
    Hoogendoorn D. Stijgend aantal gevallen van zelfmoord met veranderende methoden. Ned Tijdschr Geneeskd 1986;130:209‐12.Google Scholar
  10. 10.
    Van Harten J. Clinical pharmacokinetics of selective serotonin reuptake inhibitors. Clin Pharmacokinet 1993;24:203‐20.Google Scholar
  11. 11.
    Moleman P. Een vergelijking tussen drie serotonineheropnameremmers. Pharm Weekbl 1994;129:760‐5.Google Scholar
  12. 12.
    Den Boer JA, Westenberg HG, Effect of a serotonin and nora drenaline uptake inhibitor in panic disorder; a double‐blind comparative study with fluvoxamine and maprotiline. Int Clin Psychopharmacol 1988;3:59‐74.Google Scholar
  13. 13.
    Loonen AJM, Peer PGM, Zwanikken GJ. Continuation and maintenance therapy with antidepressive agents: a meta‐analysis of research. Pharm Weekbl [Sci] 1991:13;167‐75.Google Scholar

Copyright information

© Kluwer Academic Publishers 1997

Authors and Affiliations

  • Anton J.M. Kasteleijn‐Nolst TrenitÄ
    • 1
  1. 1.Clinical pharmacologistCentral Pharmacy of the Godshuizen's-HertogenboschThe Netherlands

Personalised recommendations